Association between Nephrolithiasis, Hypertension and Obesity in Polycystic Kidney Disease

Valbona Bajrami; Alma Idrizi; Enver Roshi; Myftar Barbullushi

doi:10.3889/oamjms.2016.010

Authors

Valbona Bajrami Diagnostic Center Ikeda, Tirana
Alma Idrizi Service of Nephrology, UHC Mother Teresa, Tirana
Enver Roshi Department of Public Health, UHC Mother Teresa, Tirana
Myftar Barbullushi Service of Nephrology, UHC Mother Teresa, Tirana

DOI:

https://doi.org/10.3889/oamjms.2016.010

Keywords:

nephrolithiasis, hypertension, polycystic kidney disease, body mass index, anatomic and metabolic factors

Abstract

AIM: We aim to define the correlations between nephrolithiasis, hypertension, age and obesity in patients with autosomal dominant polycystic kidney disease (ADPKD) in Albania.

MATERIAL AND METHODS: We included 100 patients with autosomal dominant polycystic kidney from 2011 to 2014. The patients underwent X-ray and renal ultrasonography. We performed the metabolic evaluation of blood and urine.

RESULTS: The patients with renal stones had a higher level of mean systolic and diastolic blood pressure compared with patients without stones (155 Â± 12 mmHg vs. 145 Â± 8 mmHg, and 105 Â± 0.9 mmHg vs. 92 Â± 1.28 mmHg, respectively). Patients with renal stones were older (47 Â± 15 vs. 38 Â± 5 years), had a higher prevalence of obesity [body mass index (BMI): 28 Â± 2.4 vs. 25.7 Â± 0.6], had higher levels of total cholesterol level (220 Â± 5 mg/dl vs. 203 Â± 4 mg/dl) as well as triglyceride levels (160 Â± 9 mg/dl vs. 126 Â± 4 mg/dl), compared with no renal stone individuals.

CONCLUSION: ADPKD patients with renal stones in our study had a higher mean level of systolic and diastolic blood pressure, BMI and cholesterol and triglycerides levels compared with individuals without renal stones.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Segal AJ, Spataro RF, Barbaric ZL. Adult polycystic kidney disease: a review of 100 cases. J Urol. 1967;118:711-713. DOI: https://doi.org/10.1016/S0022-5347(17)58169-0

Milutinovic J, Fialkow PJ, Agodoa LY, et al. Autosomal dominant polycystic kidney disease: Symptoms and clinical findings. Q J Med. 1984;212:511-522.

Delaney VB, Adler S, Bruns FJ, et al. Autosomal dominant polycystic kidney disease: Presentation, complications and prognosis. Am J Kidney Dis. 1985;5:104-111.

http://dx.doi.org/10.1016/S0272-6386(85)80004-4 DOI: https://doi.org/10.1016/S0272-6386(85)80004-4

Torres WE, Erickson SB, Smith LH, et al. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988;11:318-325.

http://dx.doi.org/10.1016/S0272-6386(88)80137-9 DOI: https://doi.org/10.1016/S0272-6386(88)80137-9

Levine E, Grantham JJ. Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients. Am J Roentgenol. 1992;159:77-81.

http://dx.doi.org/10.2214/ajr.159.1.1609726 DOI: https://doi.org/10.2214/ajr.159.1.1609726

Torres WE, Wilson DM, Hattery RR, et al. Renal stones disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993;22:513-519.

http://dx.doi.org/10.1016/S0272-6386(12)80922-X DOI: https://doi.org/10.1016/S0272-6386(12)80922-X

Gambaro G, Fabris A, Puliatta D, et al. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res. 2006;34:102-107.

http://dx.doi.org/10.1007/s00240-005-0019-z DOI: https://doi.org/10.1007/s00240-005-0019-z

Mufti UB, Nalagatla SK. Nephrolithiasis in autosomal dominant polycystic kidney disease. Journal of endourology / Endourological Society. 2010;24:1557-1561.

http://dx.doi.org/10.1089/end.2010.0093 DOI: https://doi.org/10.1089/end.2010.0093

Nishiura JL, et al. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. CJASN. 2009;4:838-844.

http://dx.doi.org/10.2215/cjn.03100608 DOI: https://doi.org/10.2215/CJN.03100608

Idrizi A, Barbullushi M, Gjata M, et al. Prevalence of nephrolithiasis in polycystic kidney disease. Central European Journal of Medicine. 2011;6(4):497-501.

http://dx.doi.org/10.2478/s11536-011-0043-z DOI: https://doi.org/10.2478/s11536-011-0043-z

Dimitrakov D, Simeonov S. Studies on nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Folia medica. 1994;36:27-30.

Baishya R, et al. Management of nephrolithiasis in autosomal dominant polycystic kidney disease - A single center experience. Urology annals. 2012;4:29-33.

http://dx.doi.org/10.4103/0974-7796.91618 DOI: https://doi.org/10.4103/0974-7796.91618

PMid:22346098 PMCid:PMC3271447

Idrizi A, Barbullushi M, et al. The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease. Hippokratia. 2009;13(3):161-164.

PMCid:PMC2763793

Bajwa ZH, Sial KA, Malik AB, et al. Pain patterns in patients with polycystic kidney disease. Kidney Int. 2004;66:1561-1569.

http://dx.doi.org/10.1111/j.1523-1755.2004.00921.x DOI: https://doi.org/10.1111/j.1523-1755.2004.00921.x

PMid:15458452

Ravine D, Gibson RN, Walker RG, et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease. Lancet. 1994;2:824-827.

http://dx.doi.org/10.1016/S0140-6736(94)92026-5 DOI: https://doi.org/10.1016/S0140-6736(94)92026-5

Barret BJ, Faley R, Morgan J, et al. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int. 1994;4:1118-1123.

http://dx.doi.org/10.1038/ki.1994.374 DOI: https://doi.org/10.1038/ki.1994.374

Chapman AB, Gabow PA. Hypertension in autosomal dominant polycystic kidney disease. Kidney Int Suppl. 1997;61:S71â€“73.

PMid:9328971

Gabow PA, Chapman AB, Johnson AM, et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 1990;38:1177- 1180.

http://dx.doi.org/10.1038/ki.1990.330 DOI: https://doi.org/10.1038/ki.1990.330

PMid:2074659

Chapman AB, Guay-Woodford LM, Grantham JJ, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int. 2003;64:1035â€“1045.

http://dx.doi.org/10.1046/j.1523-1755.2003.00185.x DOI: https://doi.org/10.1046/j.1523-1755.2003.00185.x

PMid:12911554

Schrier RW. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2009;20:1888â€“1893.

http://dx.doi.org/10.1681/ASN.2008080882 DOI: https://doi.org/10.1681/ASN.2008080882

PMid:19696226

Umbreit EC, et al. Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease. The Journal of urology. 2010;183:183-187.

http://dx.doi.org/10.1016/j.juro.2009.08.141 DOI: https://doi.org/10.1016/j.juro.2009.08.141

PMid:19913818

Daudon M, Cohen-Solal F, Lacour B, et al. Urinary stones and urinary tract abnormalities. Is the stone composition independent of the anatomical abnormality? Progres en urologie: journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2003;13:1320-1329.